Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
24/7 Wall St
6h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Managed Healthcare Executive
9h
IBX Excludes Coverage of Drugs with Accelerated Approvals for 18 Months
Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court rejects latest attempt
Meta drops fact-checking
Finalize their divorce
Announces $20B investment
Inmates reject clemency
Bodies found in landing gear
Pleads not guilty
Driver pleads not guilty
Sanctioned for corruption?
Biden signs RFK Stadium bill
US trade deficit widens
Antisemitic threats arrest
Folk legend Yarrow dies
Online holiday sales rise
Tesla faces US probe
French far-right leader dies
Judge halts report release
Files motion to dismiss case
SoCal windstorm warning
To lay off 4% of staff
Draws 10.1 million viewers
Job openings rise
CFPB rules on medical debt
Israeli raids in West Bank
Detainees moved to Oman
To roll back diversity goals
On China's cyber activity
Strong earthquake hits Tibet
Titans fire GM Carthon
Remains arrive in D.C.
Police reform deal approved
Related topics
Novo Nordisk
Liraglutide
Food and Drug Administration
Feedback